159 related articles for article (PubMed ID: 30113700)
1. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW
Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700
[TBL] [Abstract][Full Text] [Related]
2. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic status and hepatocellular carcinoma in the United States.
Shebl FM; Capo-Ramos DE; Graubard BI; McGlynn KA; Altekruse SF
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1330-5. PubMed ID: 22669949
[TBL] [Abstract][Full Text] [Related]
4. Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988-2012.
Pham C; Fong TL; Zhang J; Liu L
J Natl Cancer Inst; 2018 Nov; 110(11):1259-1269. PubMed ID: 29617913
[TBL] [Abstract][Full Text] [Related]
5. State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States.
Lee YT; Wang JJ; Luu M; Tseng HR; Rich NE; Lu SC; Nissen NN; Noureddin M; Singal AG; Yang JD
Hepatology; 2021 Sep; 74(3):1384-1394. PubMed ID: 33728665
[TBL] [Abstract][Full Text] [Related]
6. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
[TBL] [Abstract][Full Text] [Related]
7. Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States.
Han SS; Kelly SP; Li Y; Yang B; Nguyen M; So S; Rosenberg PS; Hsing AW
J Natl Cancer Inst; 2019 Jun; 111(6):550-556. PubMed ID: 30544184
[TBL] [Abstract][Full Text] [Related]
8. Disparities in Hepatocellular Carcinoma Incidence in California: An Update.
Sangaramoorthy M; Yang J; DeRouen MC; Ho C; Somsouk M; Tana MM; Thompson CA; Gibbons J; Gomez SL; Shariff-Marco S
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):79-87. PubMed ID: 31719066
[TBL] [Abstract][Full Text] [Related]
9. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
10. Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update.
Sangaramoorthy M; Yang J; Guan A; DeRouen MC; Tana MM; Somsouk M; Thompson CA; Gibbons J; Ho C; Chu JN; Cheng I; Gomez SL; Shariff-Marco S
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):382-392. PubMed ID: 34853019
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of hepatocellular carcinoma in Hispanics in the United States.
El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J
Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599
[TBL] [Abstract][Full Text] [Related]
12. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.
Stewart SL; Kwong SL; Bowlus CL; Nguyen TT; Maxwell AE; Bastani R; Chak EW; Chen MS
World J Gastroenterol; 2016 Oct; 22(38):8584-8595. PubMed ID: 27784971
[TBL] [Abstract][Full Text] [Related]
13. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J
Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732
[TBL] [Abstract][Full Text] [Related]
14. Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA.
El-Serag HB; Sardell R; Thrift AP; Kanwal F; Miller P
Dig Dis Sci; 2021 Mar; 66(3):912-916. PubMed ID: 32303951
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
16. Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes.
Franco RA; Fan Y; Jarosek S; Bae S; Galbraith J
Am J Prev Med; 2018 Nov; 55(5 Suppl 1):S40-S48. PubMed ID: 30670200
[TBL] [Abstract][Full Text] [Related]
17. Geographic variation within the United States in the incidence of hepatocellular carcinoma.
Davila JA; Petersena NJ; Nelson HA; El-Serag HB
J Clin Epidemiol; 2003 May; 56(5):487-93. PubMed ID: 12812824
[TBL] [Abstract][Full Text] [Related]
18. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018.
Alvarez CS; Petrick JL; Parisi D; McMahon BJ; Graubard BI; McGlynn KA
Hepatology; 2022 Sep; 76(3):589-598. PubMed ID: 35124828
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB
Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population Study.
Nautsch F; Ludwig JM; Xing M; Johnson KM; Kim HS
J Clin Gastroenterol; 2018 Mar; 52(3):262-267. PubMed ID: 28617762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]